These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Levels and associations among self-esteem, fertility distress, coping, and reaction to potentially being a genetic carrier in women with diminished ovarian reserve. Cizmeli C; Lobel M; Franasiak J; Pastore LM Fertil Steril; 2013 Jun; 99(7):2037-44.e3. PubMed ID: 23498890 [TBL] [Abstract][Full Text] [Related]
7. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hundscheid RD; Braat DD; Kiemeney LA; Smits AP; Thomas CM Hum Reprod; 2001 Mar; 16(3):457-62. PubMed ID: 11228211 [TBL] [Abstract][Full Text] [Related]
8. Evidence of early ovarian aging in fragile X premutation carriers. Welt CK; Smith PC; Taylor AE J Clin Endocrinol Metab; 2004 Sep; 89(9):4569-74. PubMed ID: 15356064 [TBL] [Abstract][Full Text] [Related]
9. X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers. Spath MA; Nillesen WN; Smits AP; Feuth TB; Braat DD; van Kessel AG; Yntema HG Am J Med Genet A; 2010 Feb; 152A(2):387-93. PubMed ID: 20101683 [TBL] [Abstract][Full Text] [Related]
10. Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency. Hoyos LR; Thakur M J Assist Reprod Genet; 2017 Mar; 34(3):315-323. PubMed ID: 27995424 [TBL] [Abstract][Full Text] [Related]
11. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Uzielli ML; Guarducci S; Lapi E; Cecconi A; Ricci U; Ricotti G; Biondi C; Scarselli B; Vieri F; Scarnato P; Gori F; Sereni A Am J Med Genet; 1999 May; 84(3):300-3. PubMed ID: 10331612 [TBL] [Abstract][Full Text] [Related]
12. An assessment of screening strategies for fragile X syndrome in the UK. Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423 [TBL] [Abstract][Full Text] [Related]
13. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Hundscheid RD; Sistermans EA; Thomas CM; Braat DD; Straatman H; Kiemeney LA; Oostra BA; Smits AP Am J Hum Genet; 2000 Feb; 66(2):413-8. PubMed ID: 10677300 [TBL] [Abstract][Full Text] [Related]
14. Ethical Dilemmas Linked to Fragile X Testing of Minors-a Preliminary Survey Among Professionals. Gabis LV; Shefer S; Raas-Rothschild A J Mol Neurosci; 2020 Feb; 70(2):254-259. PubMed ID: 31993931 [TBL] [Abstract][Full Text] [Related]
15. ACOG committee opinion. No. 338: Screening for fragile X syndrome. American College of Obstetricians and Gynecologists Committee on Genetics Obstet Gynecol; 2006 Jun; 107(6):1483-5. PubMed ID: 16738187 [TBL] [Abstract][Full Text] [Related]
17. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677 [TBL] [Abstract][Full Text] [Related]
18. Fragile X premutation screening in women with premature ovarian failure. Conway GS; Payne NN; Webb J; Murray A; Jacobs PA Hum Reprod; 1998 May; 13(5):1184-7. PubMed ID: 9647544 [TBL] [Abstract][Full Text] [Related]
19. Fragile X premutations are not a major cause of early menopause. Kenneson A; Cramer DW; Warren ST Am J Hum Genet; 1997 Dec; 61(6):1362-9. PubMed ID: 9399905 [TBL] [Abstract][Full Text] [Related]
20. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency. De Caro JJ; Dominguez C; Sherman SL Ann N Y Acad Sci; 2008; 1135():99-111. PubMed ID: 18574214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]